Search Results - susana+rodriguez

1 Results Sort By:
Use of C1q/TNF-related Protein-1 (CTRP1) to Treat Fatty Liver Disease (steatosis)
Unmet NeedObesity is a leading preventable cause of death worldwide, and it is associated with a number of comorbidities, including Non-alcoholic Fatty Liver Disease (NAFLD).  Fatty liver is the accumulation of triglycerides and other fats in the liver cells.  The amount of fatty acid in the liver depends on the balance between the processes of delivery...
Published: 9/26/2024   |   Inventor(s): Guang Wong, Susana Rodriguez
Keywords(s): Biologics, Disease Indication, Metabolic Disorders, Natural compounds, Non-novel, Predicted Novelty, Protein, Therapeutic Matter, Therapeutic Substance, Therapeutics
Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Metabolic Diseases, Technology Classifications > Therapeutic Modalities > Biologics, Technology Classifications > Therapeutic Modalities > Proteins, Technology Classifications > Therapeutic Modalities
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum